JP2009523007A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523007A5
JP2009523007A5 JP2007536171A JP2007536171A JP2009523007A5 JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5 JP 2007536171 A JP2007536171 A JP 2007536171A JP 2007536171 A JP2007536171 A JP 2007536171A JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5
Authority
JP
Japan
Prior art keywords
sequence
seq
replaced
adenovirus
batch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007536171A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523007A (ja
JP4843613B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/055183 external-priority patent/WO2006040330A2/en
Publication of JP2009523007A publication Critical patent/JP2009523007A/ja
Publication of JP2009523007A5 publication Critical patent/JP2009523007A5/ja
Application granted granted Critical
Publication of JP4843613B2 publication Critical patent/JP4843613B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007536171A 2004-10-13 2005-10-12 改良されたアデノウイルスベクターおよびその使用方法 Expired - Fee Related JP4843613B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US61846904P 2004-10-13 2004-10-13
EP04105005.5 2004-10-13
US60/618,469 2004-10-13
EP04105005 2004-10-13
US69772405P 2005-07-08 2005-07-08
US60/697,724 2005-07-08
PCT/EP2005/055183 WO2006040330A2 (en) 2004-10-13 2005-10-12 Improved adenoviral vectors and uses thereof

Publications (3)

Publication Number Publication Date
JP2009523007A JP2009523007A (ja) 2009-06-18
JP2009523007A5 true JP2009523007A5 (enExample) 2010-10-28
JP4843613B2 JP4843613B2 (ja) 2011-12-21

Family

ID=34929696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536171A Expired - Fee Related JP4843613B2 (ja) 2004-10-13 2005-10-12 改良されたアデノウイルスベクターおよびその使用方法

Country Status (6)

Country Link
JP (1) JP4843613B2 (enExample)
CN (1) CN101072879B (enExample)
AT (1) ATE492643T1 (enExample)
DE (1) DE602005025512D1 (enExample)
ES (1) ES2358523T3 (enExample)
ZA (1) ZA200702792B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039908T2 (hu) * 2009-02-02 2019-02-28 Glaxosmithkline Biologicals Sa Majom adenovírusból származó nukleinsav- és aminosav-szekvenciák, azt tartalmazó vektorok és alkalmazásuk
WO2011022002A1 (en) * 2009-08-18 2011-02-24 The Rockefeller University Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
EP2558481B1 (en) * 2010-04-14 2017-12-20 Mogam Biotechnology Research Institute Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
KR101879892B1 (ko) * 2010-12-14 2018-08-17 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 아데노바이러스 혈청형 26 및 혈청형 35 필로바일러스 백신
CN102199616B (zh) * 2011-03-07 2013-04-24 首都医科大学附属北京佑安医院 Hiv-1表型耐药检测载体及其构建方法
CA2850627C (en) * 2011-10-05 2024-05-21 Genvec, Inc. Affenadenovirus (gorilla) or adenoviral vectors and methods of use
JP5845376B2 (ja) * 2012-03-22 2016-01-20 クルセル ホランド ベー ヴェー Ｒｓｖに対するワクチン
JP7032304B2 (ja) 2015-07-28 2022-03-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア キメラ抗原受容体を発現する改変された単球／マクロファージおよびその使用
AU2017375633C1 (en) * 2016-12-12 2023-04-27 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
CN106868047B (zh) * 2017-03-07 2020-04-28 南方医科大学 一种重组腺病毒载体及其构建方法和用途
KR102582561B1 (ko) * 2017-07-05 2023-09-26 노우스콤 아게 비인간 대형 유인원 아데노바이러스 핵산-서열 및 아미노산-서열, 이를 포함하는 벡터 및 그의 용도
CN107267469B (zh) * 2017-08-22 2020-06-16 广州医科大学附属第一医院 纤毛蛋白嵌合型重组人b型腺病毒及其制备方法
MX421606B (es) * 2017-10-31 2025-03-14 Janssen Vaccines & Prevention Bv Vectores adenovirales y usos de estos
MX2020004488A (es) * 2017-10-31 2020-08-13 Janssen Vaccines & Prevention Bv Adenovirus y usos de estos.
CA3095179A1 (en) 2018-04-03 2019-10-10 Stridebio, Inc. Antibody-evading virus vectors
IL283165B2 (en) * 2018-11-21 2024-12-01 Mayo Found Medical Education & Res Adenoviruses and methods for using adenoviruses
US11542526B2 (en) * 2019-02-21 2023-01-03 Unleash Immuno Oncolytics, Inc. Oncolytic adenoviral vector and methods of use
EP4161536A4 (en) 2020-06-04 2024-08-14 Carisma Therapeutics Inc. Novel constructs for chimeric antigen receptors
CN114262692A (zh) * 2021-11-30 2022-04-01 华中科技大学同济医学院附属同济医院 一种携带tmvp1和hsv-tk的溶瘤腺病毒重组体，其构建方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US5922315A (en) * 1997-01-24 1999-07-13 Genetic Therapy, Inc. Adenoviruses having altered hexon proteins
US7344872B2 (en) * 2001-06-22 2008-03-18 The Trustees Of The University Of Pennsylvania Method for rapid screening of bacterial transformants and novel simian adenovirus proteins

Similar Documents

Publication Publication Date Title
Akusjarvi Temporal regulation of adenovirus major late alternative RNA splicing
Havenga et al. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER. C6 cells
Vogels et al. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity
Parks et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal
JP4787936B2 (ja) 癌処理への使用のためのキメラアデノウィルス
JP6970059B2 (ja) アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
Reddy et al. Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3
JP5097714B2 (ja) Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター
Reddy et al. Development of porcine adenovirus-3 as an expression vector
Amalfitano et al. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
JP2020022459A5 (enExample)
JP2014516536A5 (enExample)
JP2020022459A (ja) シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法
JP6277213B2 (ja) サルアデノウイルスベクターの増殖方法
CN1382218A (zh) 溶瘤腺病毒
JP2005505286A5 (enExample)
JP2018523980A5 (enExample)
US6844192B2 (en) Adenovirus E4 protein variants for virus production
JP2008518591A5 (enExample)
Roy et al. Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses
Lusky et al. Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3
Stone et al. The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11
JP2008510493A5 (enExample)
JP2011521661A5 (enExample)
Khatri et al. Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cellsin Vitro